109 related articles for article (PubMed ID: 1000706)
1. [Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)].
Dolezalová B; Vacek J
Cesk Psychiatr; 1976 Dec; 72(6):403-7. PubMed ID: 1000706
[No Abstract] [Full Text] [Related]
2. [Sustained levodopa efficacy in parkinsonism. Results of a four-year long-term follow-up study (author's transl)].
Schneider E; Fischer PA; Jacobi P
Nervenarzt; 1977 Apr; 48(4):205-10. PubMed ID: 404579
[No Abstract] [Full Text] [Related]
3. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
Puca FM; Megna GF; Masi G; Specchio LM
Riv Patol Nerv Ment; 1974 Oct; 95(5):676-84. PubMed ID: 4470268
[No Abstract] [Full Text] [Related]
4. The treatment with L-dopa and amantadine in Parkinson's disease.
Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I
Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
[No Abstract] [Full Text] [Related]
5. [Parosmia and anosmia under L-dopa therapy (author's transl)].
Neundörfer B; Valdivieso T
Nervenarzt; 1977 May; 48(5):283-4. PubMed ID: 895952
[No Abstract] [Full Text] [Related]
6. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
MMW Fortschr Med; 2001 May; 143 Suppl 2():93. PubMed ID: 11434272
[No Abstract] [Full Text] [Related]
7. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)].
Gründig E; Gerstenbrand F
Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702
[TBL] [Abstract][Full Text] [Related]
8. [Crises in the course of Parkinson's disease].
Danielczyk W
Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682
[No Abstract] [Full Text] [Related]
9. [Edemas and myocloni concerning a patient with Parkinson's disease treated by amantadine (author's transl)].
Chevalier JF; Renier E; Brion S
Encephale; 1980; 6(4):381-4. PubMed ID: 7439114
[TBL] [Abstract][Full Text] [Related]
10. [The problem of side effects after a treatment with L-dopa in the Parkinson's syndrome: clinical and animal studies (author's transl)].
Sommer H; Fischer GJ; Quandt J
Folia Clin Int (Barc); 1974 Oct; 24(10):681-95. PubMed ID: 4279185
[No Abstract] [Full Text] [Related]
11. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
Peiró Grasa A; Grau-Veciana JM
Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630
[No Abstract] [Full Text] [Related]
12. [Influencing of the rate of taking root of the tumor by L-dopa, amantadine and measles vaccine in combination with gamma radiation (author's transl)].
Busse E; Rose H; Helmholz M; Krüger B
Radiobiol Radiother (Berl); 1980; 21(6):788-93. PubMed ID: 6264540
[No Abstract] [Full Text] [Related]
13. [Problems in the administration of L-DOPA (author's transl)].
Ferrari E
Riv Patol Nerv Ment; 1974 Aug; 95(4):239-50. PubMed ID: 4283417
[No Abstract] [Full Text] [Related]
14. [Progress in therapy of Parkinsonian syndrome].
Völler GW
Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
[No Abstract] [Full Text] [Related]
15. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
[No Abstract] [Full Text] [Related]
16. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
Blanchet PJ; Konitsiotis S; Chase TN
Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
[TBL] [Abstract][Full Text] [Related]
17. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Schneider E; Fischer PA; Jacobi P
Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
[No Abstract] [Full Text] [Related]
18. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease].
Dzudza M; Dzudza D
Med Arh; 1974; 28(4):407-15. PubMed ID: 4613968
[No Abstract] [Full Text] [Related]
19. Parkinson's disease.
Lieberman AN
Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
[No Abstract] [Full Text] [Related]
20. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
